NCT01673451View on ClinicalTrials.gov

2-Part Multiple Ascending Dose Study for Safety and Pharmacokinetics in Healthy and Elderly Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

July 31, 2013

Conditions
CNS
Interventions
DRUG

E2006

Part A: 2.5 mg, 5 mg, 10 mg, 25 mg, 50 mg, and 75 mg E2006 administered as capsules

DRUG

Placebo comparator

E2006-matched placebo (Part A and Part B); Part B: dose level to be determined based on results of Part A, administered as capsules

Trial Locations (2)

90232

Parexel, California Clinical Trials, Culver City

91206

Glendale

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT01673451 - 2-Part Multiple Ascending Dose Study for Safety and Pharmacokinetics in Healthy and Elderly Subjects | Biotech Hunter | Biotech Hunter